4 quarters tracked · Beat rate 50% · Updated quarterly
| Period | Report Date | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | $0.55 | $0.53 | -3.3% | Miss |
| Q2 2026 | 2025-12-31 | $0.44 | $0.46 | +4.0% | Beat |
| Q1 2026 | 2025-09-30 | $0.43 | $0.42 | -2.0% | Miss |
| Q4 2025 | 2025-06-30 | $0.51 | $0.53 | +4.1% | Beat |
Earnings Beat Rate
Bio-Techne has beaten analyst EPS estimates in 2 of 4 tracked quarters (50% beat rate). Data sourced from SEC filings and analyst consensus. View full AI analysis →